课题基金 / 基金详情

项目摘要

项目成果

PETER M GLAZER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This application proposes that Yale University become a Network Lead Academic Participating Site (LAPS) under the newly established NCI National Clinical Trials Network. As an LAPS Yale University will 1. Promote and advocate for NCTN clinical research at the Yale Comprehensive Cancer Center (YCC); 2.continue expanding accrual to NCTN trials and provide broad based access to these important national trials to YCC membership; 3. Provide the scientific leadership necessary in order to advance the cause of NCI funded research in the NCTN system and lead important trials that will advance cancer treatment and standard of care; 4. Provide the translational science and laboratory support for these NCTN clinical trials; 5. Train and mentor Young Investigators in the NCTN groups and help them to provide the next generation of scientific leadership
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PNA Nanoparticles for Gene Editing In Vivo
  • 批准号:
    10198735
  • 项目类别:
  • 资助金额:
    $40.42万
  • 财政年份:
    2019
  • 负责人:
    PETER M GLAZER
  • 依托单位:
PNA Nanoparticles for Gene Editing In Vivo
  • 批准号:
    9804726
  • 项目类别:
  • 资助金额:
    $42.11万
  • 财政年份:
    2019
  • 负责人:
    PETER M GLAZER
  • 依托单位:
PNA Nanoparticles for Gene Editing In Vivo
  • 批准号:
    10414795
  • 项目类别:
  • 资助金额:
    $40.42万
  • 财政年份:
    2019
  • 负责人:
    PETER M GLAZER
  • 依托单位:
Poly(amine-co-ester)s for Targeted Delivery In Vivo of Gene Editing Agents to Bone Marrow and Lung
  • 批准号:
    10274829
  • 项目类别:
  • 资助金额:
    $75.68万
  • 财政年份:
    2018
  • 负责人:
    PETER M GLAZER
  • 依托单位:
海外基金